ARTICLE | Distillery Therapeutics
Synthetic fusion protein system for EGFR- and HER2-positive cancers
May 28, 2019 5:54 PM UTC
INDICATION: Breast cancer; brain cancer; non-small cell lung cancer (NSCLC); pancreatic cancer...
BCIQ Company Profiles
INDICATION: Breast cancer; brain cancer; non-small cell lung cancer (NSCLC); pancreatic cancer...
BCIQ Company Profiles
BCIQ Company Profiles